Welcome to the Leibniz-Institut für Molekulare Pharmakologie (FMP)

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.

Research Highlights

Entry from: 22.01.2016  
Category: Research Highlights

Milestone for Parkinson's research: The amyloid protein α-synuclein has been visualised in the cell for the first time

NATURE AND NATURE COMMUNICATIONS The protein α-synuclein plays an important role in Parkinson's and other neurodegenerative diseases. Although a considerable amount is known about the structure of the protein within the Parkinson's-typical amyloid deposits, (...)[more]

Entry from: 13.01.2016  
Category: Research Highlights

Muscle weakness: Berlin scientists unravel defects in rare hereditary disease myotubular myopathy

NATURE Tiny deviations in the body's cells can sometimes have severe consequences. Researchers from Berlin have discovered why cells from patients suffering from the rare muscular disease myotubular myopathy cannot function properly. Through the paper published (...)[more]

Entry from: 10.12.2015  
Category: Research Highlights

Uptake mechanisms of cytostatics discovered

EMBO JOURNAL How does a cytostatic like cisplatin or carboplatin actually get into the cell? Scientists at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and the Leibniz-Institut für Molekulare Pharmakologie (FMP) in Berlin, in (...)[more]

Entry from: 10.12.2015  
Category: Research Highlights

Down to the atom: Bacterial skeleton in close-up

PNAS AND SCIENCE ADVANCES For a long time, bacteria were considered to be primitive structures, and it was not until the most modern of imaging techniques were used that their fine inner structure was discovered. The Berlin biophysicist Adam Lange has now (...)[more]

Entry from: 25.09.2015  
Category: Research Highlights

A synaptic governess

NEURON AND NATURE COMMUNICATIONS Protein AP180 plays a subtle role in neurotransmission. It ensures the efficient recycling of a synaptic vesicle protein during high neuronal activity. Loss of AP180 has astounding effects on behavioral patterns in animal (...)[more]


Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)